Literature DB >> 23120345

Rhinoplasty and young's operation in atrophic rhinitis.

Swapan Kr Ghosh1, Asok Kr Saha, Rakesh Ranjan.   

Abstract

Rhinoplasty in atrophic rhinitis is a difficult surgery because the dorsal skin is adherent to the underlying structures. There is also more chance of postoperative injection. Our experience of various types of rhinoplasly in 25 atrophic rhinitis patients are presented here. The patients were from the age group 16 to 35 years. Most of the operations were done under local anaesthesia. Commonest graft used was conchal cartilage. Bone graft was avoided for augmentation because of its high rate of absorption in atrophic rhinitis. In 10 patients Young's operation was done in one side along with rhinoplasty. Young's operation was done only with skin layer.

Entities:  

Keywords:  Atrophic rhinitis; Rhinoplasty; Young’s operation

Year:  2006        PMID: 23120345      PMCID: PMC3450366          DOI: 10.1007/BF03049592

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  6 in total

1.  Incision and scar analysis in open (external) rhinoplasty.

Authors:  P A Adamson; O Smith; G J Tropper
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-06

2.  Surgical treatment of ozena by dermofat graft.

Authors:  I H Girgis
Journal:  J Laryngol Otol       Date:  1966-06       Impact factor: 1.469

3.  Septo-rhinoplasty: applied anatomy and physiology.

Authors:  R T Wentges
Journal:  J Laryngol Otol       Date:  1980-05       Impact factor: 1.469

4.  Septo-rhinoplasty: surgery of the nasal tip by external rhinoplasty.

Authors:  W S Goodman
Journal:  J Laryngol Otol       Date:  1980-05       Impact factor: 1.469

5.  Septo-rhinoplasty: the correction of the bony parts of the nose.

Authors:  C Walter
Journal:  J Laryngol Otol       Date:  1980-05       Impact factor: 1.469

6.  Management of saddle nose deformity in atrophic rhinitis.

Authors:  B Baser; D S Grewal; N L Hiranandani
Journal:  J Laryngol Otol       Date:  1990-05       Impact factor: 1.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.